Transaction #15497 · Form 4 · 0001796960-25-000008
INSMED Inc · Exercise / conversion · Common Stock
INSMED Inc · Transacted December 1, 2025 · Filed December 3, 2025
What does this filing report?
An SEC Form 4 filing for INSMED Inc records an exercise / conversion involving Common Stock on December 1, 2025. The reported quantity was 8,895. The filing date is December 3, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- INSMED Inc
- Company CIK
- 0001104506
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 8,895
- Reported price
- 25.83
- Reference value
- 229,757.85
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 92,006
- Ownership description
- Not reported
- SEC acceptance time
- Dec 3, 2025, 4:01 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Flammer Martina M.D. ↗
Chief Medical Officer
CIK 0001796960
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2
- This is the weighted average sales price representing 1,450 shares sold at prices ranging from $205.45 to $206.39 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F3
- This is the weighted average sales price representing 5,886 shares sold at prices ranging from $206.48 to $207.47 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F4
- This is the weighted average sales price representing 1,559 shares sold at prices ranging from $207.49 to $208.17 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F5
- The options become exercisable based on the following vesting schedule: 25% vest on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the Initial Vesting Date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.